0000821995-10-000047.txt : 20100715 0000821995-10-000047.hdr.sgml : 20100715 20100715152753 ACCESSION NUMBER: 0000821995-10-000047 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100715 DATE AS OF CHANGE: 20100715 EFFECTIVENESS DATE: 20100715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA LABORATORIES INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-145047 FILM NUMBER: 10954273 BUSINESS ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 BUSINESS PHONE: 9739943999 MAIL ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 D 1 primary_doc.xml X0704 D LIVE 0000821995 COLUMBIA LABORATORIES INC 354 EISENHOWER PARKWAY LIVINGSTON NJ NEW JERSEY 07039 9739943999 DELAWARE Columbia Consumer Pharmaceuticals, Inc. None Corporation true Frank C. Condella 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Executive Officer Director Lawrence A. Gyenes 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Executive Officer Michael McGrane 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Executive Officer Stephen G. Kasnet 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director Edward A. Blechschmidt 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director Valerie L. Andrews 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director Anthony R. Campbell 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director James S. Crofton 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director Selwyn P. Oskowitz, M.D. 354 Eisenhower Parkway Plaza 1, Second Floor Livingston NJ NEW JERSEY 07039 Director Pharmaceuticals Decline to Disclose 06 false 2010-07-02 false true true false 9573 24528629 24528629 0 Only for purposes of this Form D, the shares of Common Stock are valued at $1.03 per share (the closing price on July 2, 2010) and the warrants are valued at $0.692 per warrant. false 25 0 0 As more fully described in Columbia Laboratory, Inc.'s (the "Company") proxy statement, dated June 1, 2010, the Company paid Torreya Partners LLC a fee for investment banking services as described in that proxy statement. 1624246 true In exchange for $5,000,000 of the Company's notes, Dorset Management Corp. & David Knott, affiliates of Anthony R. Campbell (a member of the Company's board) received $3,250,000, 925,926 shares of Common Stock & warrants to purchase 7,750,000 shares. false COLUMBIA LABORATORIES INC Frank C Condella, Jr Frank C Condella, Jr President & CEO 2010-07-13